SCHEMBL479371

SCHEMBL479371

C=C(C)C(=O)N1CCNCC1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA9 Q16790 1/20 0.46
CHKA P35790 1/20 0.45
CHRNB2 P17787 1/20 0.43
CHRNA3 P32297 1/20 0.43
CHRNA4 P43681 1/20 0.43
CHRNB3 Q05901 1/20 0.43
CHRNA6 Q15825 1/20 0.43
SIGMAR1 Q99720 1/20 0.38
HSD11B1 P28845 1/20 0.37
HPGD P15428 1/20 0.36
POLB P06746 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
EPHX2 P34913 1/20 0.34
HSP90AA1 P07900 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7941525 0.89 CA2 (0.38) CA2CA12CA1CA9CHKA
Pyrimidine SCHEMBL28041833 0.84 MKNK1 (0.40) CA2CA12CA1CA9CHKA
SCHEMBL236549 0.83
SCHEMBL269621 0.83 TDP1 (0.42) POLB
SCHEMBL6985542 0.81 CA2 (0.50) CA2CA12CA1CA9CHKA
SCHEMBL9396214 0.80 CA2 (0.59) CA2CA12CA1CA9CHKA
SCHEMBL5131814 0.78
SCHEMBL109476 0.78 ALDH1A1 (0.42) CA2CHKAHPGD
SCHEMBL23985980 0.77 CA2 (0.46) CA2CA12CA1CA9CHKA
SCHEMBL19617739 0.77 CHRNB2 (0.44) CA2CA12CA1CA9CHKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250250381-A1 METHODS OF SYNTHESIZING DIALYKYLAMINO DISULFIDE DYNAMIC CROSSLINKERS BRASKEM AMERICA INC (US) 2025-08-07 US claimed
EP-4304842-A1 METHOD FOR MAKING PHOTOFUNCTIONAL CONTACT LENSES Alcon Inc. (CH) 2024-01-17 EP claimed
EP-3969268-A1 METHOD FOR PRODUCING PHOTOCHROMIC CONTACT LENSES Alcon Inc. (CH) 2022-03-23 EP claimed
EP-3802081-A1 METHOD FOR PRODUCING SILICONE HYDROGEL CONTACT LENSES Alcon Inc. (CH) 2021-04-14 EP claimed
EP-3802082-A1 METHOD FOR PRODUCING SILICONE HYDROGEL CONTACT LENSES Alcon Inc. (CH) 2021-04-14 EP claimed
EP-3802080-A1 METHOD FOR MAKING SILICONE HYDROGEL CONTACT LENSES Alcon Inc. (CH) 2021-04-14 EP claimed
WO-2020230016-A1 METHOD FOR PRODUCING PHOTOCHROMIC CONTACT LENSES ALCON INC. (CH) 2020-11-19 WO claimed
EP-3526277-A1 POLYMERIZABLE POLYDIMETHYLSILOXANE-POLYOXYALKYLENE BLOCK COPOLYMERS Novartis AG (CH) 2019-08-21 EP claimed
EP-3526278-A1 CHAIN-EXTENDED POLYDIMETHYLSILOXANE VINYLIC CROSSLINKERS AND USES THEREOF Novartis AG (CH) 2019-08-21 EP claimed
EP-3390498-A1 HYDROPHILIZED POLYDIORGANOSILOXANE VINYLIC CROSSLINKERS AND USES THEREOF Novartis AG (CH) 2018-10-24 EP claimed
EP-0728826-B1 Compositions comprising an acrylamide-containing polymer and use PHILLIPS PETROLEUM CO (US) 2001-08-08 EP claimed
CN-1065889-C Composite composed of polymer containing acrylicamide and its use method PHILLIPS PETROLEUM CO (US) 2001-05-16 CN claimed
US-6124245-A Drilling fluid additive and process therewith PHILLIPS PETROLEUM COMPANY (US) 2000-09-26 US claimed
US-5693698-A Compositions comprising an acrylamide-containing polymer and process therewith PHILLIPS PETROLEUM COMPANY (US) 1997-12-02 US claimed
US-5684075-A POLYOXYPROPYLENE GLYCOL PHILLIPS PETROLEUM COMPANY (US) 1997-11-04 US claimed
EP-0728826-A1 Compositions comprising an acrylamide-containing polymer and process therewith PHILLIPS PETROLEUM COMPANY (US) 1996-08-28 EP claimed
EP-0714275-A1 POLYMERS IN COSMETICS AND PERSONAL CARE PRODUCTS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1996-06-05 EP claimed
EP-0639969-A1 POLYMERS IN COSMETICS AND PERSONAL CARE PRODUCTS. MINNESOTA MINING & MFG (US) 1995-03-01 EP claimed
WO-1995003776-A1 POLYMERS IN COSMETICS AND PERSONAL CARE PRODUCTS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1995-02-09 WO claimed
WO-1993023009-A1 POLYMERS IN COSMETICS AND PERSONAL CARE PRODUCTS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1993-11-25 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250250381-A1 METHODS OF SYNTHESIZING DIALYKYLAMINO DISULFIDE DYNAMIC CROSSLINKERS CBS, TST, PDIA4 CA2 3852/4885CA12 2015/4885CA1 2467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.